Literature DB >> 16171441

The Basal phosphorylation sites of endothelial nitric oxide synthase at serine (Ser)1177, Ser116, and threonine (Thr)495 in rat molar epithelial rests of Malassez.

Yüksel Korkmaz1, Wilhelm Bloch, Klaus Addicks, Kurt Schneider, Michael A Baumann, Wolfgang H-M Raab.   

Abstract

BACKGROUND: The epithelial rests of Malassez (ERM) are derived from the Hertwig's epithelial root sheath during tooth development. The ERM contain endothelial nitric oxide synthase (eNOS), but the existence of phosphorylation site/s of eNOS in the ERM is unclear.
METHODS: Rat molars with periodontium were perfusion- and post-fixed, decalcified, and frozen-sectioned. Free-floating sections were incubated using antisera against total eNOS, eNOS phosphorylated at serine (Ser)1177, Ser116, and threonine (Thr)495. The signal intensities of t-eNOS, p-eNOS at Ser1177 and Ser116 in the ERM were measured by densitometry and statistically analyzed.
RESULTS: In the ERM, localization of total eNOS and the phosphorylation sites of eNOS at Ser1177 and Ser116 were detected, while a basal localization of eNOS phosphorylated at Thr495 in the ERM was undetectable. For p-eNOS at Ser116 regional differences in phosphorylation were detected.
CONCLUSIONS: The basal production of NO by eNOS in the ERM is modulated by phosphorylation of eNOS at Ser1177 and Ser116 residues, while the basal activity of the eNOS is not influenced by phosphorylation of eNOS at Thr495 residue. This provides evidence that phosphorylation plays a key role for regulation of the catalytic activity of eNOS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16171441     DOI: 10.1902/jop.2005.76.9.1513

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  2 in total

Review 1.  Production and physiological role of NO in the oral cavity.

Authors:  Kimiharu Ambe; Hiroki Watanabe; Shinya Takahashi; Toshihiro Nakagawa; Junzo Sasaki
Journal:  Jpn Dent Sci Rev       Date:  2015-09-11

2.  Atorvastatin downregulates HSP22 expression in an atherosclerotic model in vitro and in vivo.

Authors:  Qi Chen; Jian Xiang; Ren Gong; Hai-Yang Fang; Cong-Cong Xu; Hong-Zhou Zhang; Yan-Qing Wu
Journal:  Int J Mol Med       Date:  2018-12-03       Impact factor: 4.101

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.